Neurocrine biosciences to participate at investor conferences in march

Barclays global healthcare conference on march 15 in miami jefferies biotech on the bay summit on march 16 in miami san diego , march 8, 2023 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) will participate at two upcoming investor conferences in march. kevin gorman, chief executive officer, and matt abernethy, chief financial officer, will present at the barclays global healthcare conference at 10:45 a.m.
NBIX Ratings Summary
NBIX Quant Ranking